General Medicine and Primary Care - Global Oncology Academy

33-48 of 117

Stories in PNH: Case Experiences from the Clinic
Stories in PNH: Case Experiences from the Clinic
Project Oncology®
Stories in PNH: Case Experiences from the Clinic
Charles Turck, PharmD, BCPS, BCCCP; Timothy Kubal, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Timothy Kubal, MD
Next-Generation Horizons in PNH Therapies
Next-Generation Horizons in PNH Therapies
Project Oncology®
Next-Generation Horizons in PNH Therapies
Vinod Pullarkat, MD
- Vinod Pullarkat, MD
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
Understanding the Role of the Alternate Complement Pathway in PNH
Understanding the Role of the Alternate Complement Pathway in PNH
Project Oncology®
Understanding the Role of the Alternate Complement Pathway in PNH
Jennifer Caudle, DO, FACOFP; Catherine Broome, MD
- Jennifer Caudle, DO, FACOFP
- Catherine Broome, MD
Managing PNH: Clinical Considerations
Managing PNH: Clinical Considerations
Project Oncology®
Managing PNH: Clinical Considerations
Charles Turck, PharmD, BCPS, BCCCP; Jamie Koprivnikar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Jamie Koprivnikar, MD
- Abdulraheem Yacoub, MD
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
Obesity and Cancer Screening: National Trends and Disparities Revealed
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's Roundtable
Obesity and Cancer Screening: National Trends and Disparities Revealed
Vance Albaugh, MD, PhD
- Vance Albaugh, MD, PhD
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Global Oncology Academy
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Gerard A. Silvestri MD, MS; Jessica S. Donington, MD, MSCR
- Gerard A. Silvestri MD, MS
- Jessica S. Donington, MD, MSCR
- Mariam Alexander, MD, PhD
- Anurag Singh, MD
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Global Oncology Academy
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Gerard A. Silvestri MD, MS; Jessica S. Donington, MD, MSCR
- Gerard A. Silvestri MD, MS
- Jessica S. Donington, MD, MSCR
- Mariam Alexander, MD, PhD
- Anurag Singh, MD
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Ryan Quigley
- Ryan Quigley
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley; Hallie Blevins, PhD
- Ryan Quigley
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Marlene Mimi Maeusli, PhD.
- Marlene Mimi Maeusli, PhD.
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Ryan Quigley
- Ryan Quigley
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Ryan Quigley
- Ryan Quigley
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
On the Frontlines of Prostate Cancer
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
Wayne Kuang, MD; William Oh, MD
- Wayne Kuang, MD
- William Oh, MD
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
On the Frontlines of Prostate Cancer
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
William Oh, MD
- William Oh, MD

3/8